Cited 0 time in
Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kim, Do Young | - |
| dc.contributor.author | Shin, Ho-Jin | - |
| dc.contributor.author | Min, Chang-Ki | - |
| dc.contributor.author | Eom, Hyeon-Seok | - |
| dc.contributor.author | Jung, Jongheon | - |
| dc.contributor.author | Kim, Kihyun | - |
| dc.contributor.author | Lee, Jae Hoon | - |
| dc.contributor.author | Yoo, Kwai Han | - |
| dc.contributor.author | Lee, Ji Yun | - |
| dc.contributor.author | Byun, Ja Min | - |
| dc.contributor.author | Kim, Sung-Hyun | - |
| dc.contributor.author | Lee, Ji Hyun | - |
| dc.contributor.author | Cho, Hee Jeong | - |
| dc.contributor.author | Lee, Sang Min | - |
| dc.contributor.author | Do, Young Rok | - |
| dc.contributor.author | Park, Sungwoo | - |
| dc.contributor.author | Lee, Junglim | - |
| dc.contributor.author | Lee, Seung-Shin | - |
| dc.contributor.author | Kang, Hye Jin | - |
| dc.contributor.author | Park, Young Hoon | - |
| dc.contributor.author | Lim, Sung-Nam | - |
| dc.date.accessioned | 2023-11-20T07:42:29Z | - |
| dc.date.available | 2023-11-20T07:42:29Z | - |
| dc.date.issued | 2023-09 | - |
| dc.identifier.issn | 2152-2650 | - |
| dc.identifier.issn | 2152-2669 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/68545 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Cancer Media Group | - |
| dc.title | Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.wosid | 001079705400331 | - |
| dc.identifier.bibliographicCitation | Clinical Lymphoma, Myeloma and Leukemia, v.23, pp S189 - S190 | - |
| dc.citation.title | Clinical Lymphoma, Myeloma and Leukemia | - |
| dc.citation.volume | 23 | - |
| dc.citation.startPage | S189 | - |
| dc.citation.endPage | S190 | - |
| dc.type.docType | Meeting Abstract | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Oncology | - |
| dc.relation.journalResearchArea | Hematology | - |
| dc.relation.journalWebOfScienceCategory | Oncology | - |
| dc.relation.journalWebOfScienceCategory | Hematology | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
